215 related articles for article (PubMed ID: 17584096)
1. Smoking, haemostatic factors, and cardiovascular risk.
Leone A
Curr Pharm Des; 2007; 13(16):1661-7. PubMed ID: 17584096
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
[TBL] [Abstract][Full Text] [Related]
3. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
Roy S
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
[TBL] [Abstract][Full Text] [Related]
4. [Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):137-47. PubMed ID: 15969316
[TBL] [Abstract][Full Text] [Related]
5. The biology behind the atherothrombotic effects of cigarette smoke.
Csordas A; Bernhard D
Nat Rev Cardiol; 2013 Apr; 10(4):219-30. PubMed ID: 23380975
[TBL] [Abstract][Full Text] [Related]
6. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.
Soma P; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
Castelli WP
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
[TBL] [Abstract][Full Text] [Related]
8. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Newby DE; Wright RA; Labinjoh C; Ludlam CA; Fox KA; Boon NA; Webb DJ
Circulation; 1999 Mar; 99(11):1411-5. PubMed ID: 10086962
[TBL] [Abstract][Full Text] [Related]
10. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.
Otamas A; Grant PJ; Ajjan RA
Diab Vasc Dis Res; 2020; 17(3):1479164120920582. PubMed ID: 32506946
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
13. Cigarette Smoking and Atherosclerotic Cardiovascular Disease.
Ishida M; Sakai C; Kobayashi Y; Ishida T
J Atheroscler Thromb; 2024 Mar; 31(3):189-200. PubMed ID: 38220184
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link?
Chia S; Newby DE
Curr Atheroscler Rep; 2002 Mar; 4(2):143-8. PubMed ID: 11822978
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
Kryczka KE; Kruk M; Demkow M; Lubiszewska B
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356659
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
17. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
18. Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Kearney K; Tomlinson D; Smith K; Ajjan R
Cardiovasc Diabetol; 2017 Mar; 16(1):34. PubMed ID: 28279217
[TBL] [Abstract][Full Text] [Related]
19. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Ambrose JA
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):75-9. PubMed ID: 19815816
[TBL] [Abstract][Full Text] [Related]
20. Plasma Fibrinolysis Parameters in Smokers and Non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Delgado GE; Siekmeier R; Krämer BK; März W; Kleber ME
Adv Exp Med Biol; 2015; 858():69-77. PubMed ID: 25786403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
